Diversified Healthcare Trust

Q2 FY2026 EarningsQ2 FY26 results were characterized by a lack of fundamental data in the preliminary release, though management confirmed that FY26 full-year guidance remains consistent with the June 1 outlook. Reported revenue and earnings per share (EPS) metrics were missing from the summary exhibit, leaving performance relative to the $370.8M revenue and -$0.15 normalized EPS consensus unconfirmed pending the full 10-Q filing. The portfolio remains stable at $6.3B across 285 properties, with a focus on senior housing and life sciences assets.